DK3818059T3 - Mellemprodukter i syntese af c3-substituerede cephalosporiner - Google Patents

Mellemprodukter i syntese af c3-substituerede cephalosporiner Download PDF

Info

Publication number
DK3818059T3
DK3818059T3 DK19736478.9T DK19736478T DK3818059T3 DK 3818059 T3 DK3818059 T3 DK 3818059T3 DK 19736478 T DK19736478 T DK 19736478T DK 3818059 T3 DK3818059 T3 DK 3818059T3
Authority
DK
Denmark
Prior art keywords
intermediates
synthesis
substituted cephalosporins
cephalosporins
substituted
Prior art date
Application number
DK19736478.9T
Other languages
English (en)
Inventor
Karolina Madela
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Application granted granted Critical
Publication of DK3818059T3 publication Critical patent/DK3818059T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • C07D463/18Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/08Preparation by forming the ring or condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/08Preparation by forming the ring or condensed ring systems
    • C07D501/10Preparation by forming the ring or condensed ring systems from compounds containing the penicillin ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C07C45/676Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton by elimination of carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Fodder In General (AREA)
DK19736478.9T 2018-07-02 2019-07-02 Mellemprodukter i syntese af c3-substituerede cephalosporiner DK3818059T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1810849.8A GB2575261B (en) 2018-07-02 2018-07-02 Intermediates in the synthesis of C3-substituted cephalosporins
PCT/GB2019/051871 WO2020008183A1 (en) 2018-07-02 2019-07-02 Intermediates in the synthesis of c3-substituted cephalosporins

Publications (1)

Publication Number Publication Date
DK3818059T3 true DK3818059T3 (da) 2024-08-19

Family

ID=63143782

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19736478.9T DK3818059T3 (da) 2018-07-02 2019-07-02 Mellemprodukter i syntese af c3-substituerede cephalosporiner

Country Status (13)

Country Link
US (1) US11840544B2 (da)
EP (1) EP3818059B1 (da)
AU (1) AU2019298749B2 (da)
CA (1) CA3104110A1 (da)
DK (1) DK3818059T3 (da)
ES (1) ES2985585T3 (da)
FI (1) FI3818059T3 (da)
GB (1) GB2575261B (da)
HR (1) HRP20241106T1 (da)
PL (1) PL3818059T3 (da)
PT (1) PT3818059T (da)
SI (1) SI3818059T1 (da)
WO (1) WO2020008183A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111763221A (zh) * 2020-07-31 2020-10-13 重庆医药高等专科学校 一种头孢维星中间体及其制备方法
CN111892612A (zh) * 2020-07-31 2020-11-06 重庆医药高等专科学校 一种以青霉素钾盐为原料制备头孢维星的中间体异构化物及其制备方法
CN112409382A (zh) * 2020-11-26 2021-02-26 浙江普洛得邦制药有限公司 一种盐酸头孢他美酯的合成方法
CN115873021A (zh) * 2022-12-19 2023-03-31 华北制药集团动物保健品有限责任公司 一种头孢维星钠的制备方法
CN117186116B (zh) * 2023-09-07 2024-06-07 浙江荣耀生物科技股份有限公司 一种头孢维星中间体的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones
MY106399A (en) 1990-07-24 1995-05-30 Pfizer Cephalosporins and homologeus, preparation and pharmaceutical composition
GB2300856A (en) 1995-05-16 1996-11-20 Pfizer Ltd Beta-lactam preparation
GB0019124D0 (en) 2000-08-03 2000-09-27 Pfizer Novel process
IL155714A0 (en) 2000-12-04 2003-11-23 Pfizer Prod Inc Coupling process and intermediates useful for preparing cephalosphorins
EP1339723B1 (en) 2000-12-04 2006-03-08 Pfizer Products Inc. Process and ester derivatives useful for preparation of cephalosporins
US7378408B2 (en) 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
CN1930173A (zh) 2004-03-09 2007-03-14 辉瑞产品公司 使用α-碘代-1-氮杂环丁烷乙酸酯和三烷基亚磷酸盐制备头孢菌素中间体的方法
US7560575B2 (en) * 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
WO2010117796A2 (en) * 2009-03-30 2010-10-14 Codexis, Inc. Processes for the preparation of alpha-chloroketones from carboxylic acids

Also Published As

Publication number Publication date
PT3818059T (pt) 2024-08-16
AU2019298749B2 (en) 2024-04-11
FI3818059T3 (fi) 2024-08-14
EP3818059B1 (en) 2024-05-22
US20210261571A1 (en) 2021-08-26
GB2575261A (en) 2020-01-08
SI3818059T1 (sl) 2024-10-30
US11840544B2 (en) 2023-12-12
EP3818059A1 (en) 2021-05-12
CA3104110A1 (en) 2020-01-09
PL3818059T3 (pl) 2024-09-30
ES2985585T3 (es) 2024-11-06
GB201810849D0 (en) 2018-08-15
AU2019298749A1 (en) 2021-01-28
HRP20241106T1 (hr) 2024-11-08
GB2575261B (en) 2022-03-09
WO2020008183A1 (en) 2020-01-09

Similar Documents

Publication Publication Date Title
DK3810581T3 (da) Krystalmodifikationer af odevixibat
IL282775A (en) Selection of improved tumor reactive t-cells
DK3512850T3 (da) Inhibitorer af menin-mll-interaktionen
DK3468966T3 (da) Inhibitorer af menin-mll-interaktionen
DK3818059T3 (da) Mellemprodukter i syntese af c3-substituerede cephalosporiner
HUE055242T2 (hu) Omecamtiv mecarbil szintézise
DK3833662T3 (da) Inhibitorer af protein-protein-interaktionen mellem KEAP-1-NRF2-
EP4081547A4 (en) Novel anti-fgfr2b antibodies
EP3847825A4 (en) ACOUSTIC ZOOMING
EP3506254A4 (en) SOUNDPROOF STRUCTURE
EP4081539A4 (en) Novel anti-fgfr2b antibodies
DK3830073T3 (da) Fremgangsmåde til monotopisk fremstilling af iodorganske mellemforbindelser til syntese af ioversol
IL284374A (en) Methods of producing ustekinumab
DK3580197T3 (da) Oprensning af pleuromutilin
HUE069611T2 (hu) Eljárások upadacitinib és intermedierjei szintézisére
DK3759415T3 (da) Konverteringssæt med udskiftlige løbsforinger
EP3866808A4 (en) NEW USES
PL3830088T3 (pl) Synteza koelenterazyny
EP3833758A4 (en) Novel transcription activator
DK3774844T3 (da) Krystallinske dipeptider, der er anvendelige i syntese af elamipretid
PL3752129T3 (pl) Wielofunkcyjna kompozycja torasemidu
IL285119A (en) Use of spiropidion
DK3746279T3 (da) Sammenkobling af formdele
EP3852209C0 (en) OPTICAL OSCILLATOR
DK3558920T3 (da) Forbedret syntese af lysinacetylsalicylat-glycin-partikler